Skip to main content
Erschienen in: Diabetologia 8/2005

01.08.2005 | Article

Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins

verfasst von: M. Lehtovirta, J. Kaprio, L. Groop, M. Trombetta, R. C. Bonadonna

Erschienen in: Diabetologia | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The genetic architecture of model-derived parameters of beta cell function has never been assessed. Therefore, we estimated heritability (h 2) for model-derived phenotypes of insulin secretion in twins.

Methods

Thirty-three monozygotic (MZ) and 23 dizygotic (DZ) twin pairs from the Finnish Twin Cohort Study underwent an OGTT (plasma glucose/C-peptide at 0, 30, 60, 90 and 120 min). A subset of the twin pairs (21 MZ/20 DZ) also underwent an IVGTT (frequent sampling of plasma glucose/insulin from 0 to 60 min) followed by a 160-min euglycaemic–hyperinsulinaemic clamp (45 mU·min−1·m−2). Mathematical modelling was applied to the IVGTT and the OGTT to assess first-phase (readily releasable insulin [RRI]) and second-phase (sigma) secretion (IVGTT), and a global index of beta cell performance (OGTT beta index). Intraclass correlation coefficients and genetic and non-genetic components for trait variances were computed to assess the h 2 of model-derived parameters.

Results

The intraclass correlation coefficients in MZ twins were 0.78 for RRI, 0.67 for sigma and 0.57 for OGTT beta index. In DZ twins the correlation coefficients were 0.23, 0.32 and 0.42, respectively. Using the most parsimonious model for each trait, the h 2 – the proportion of variance accounted for by genetic factors – was 76% (95% CI: 53–88%) for RRI, 28% (34–80%) for sigma and 53% (26–72%) for OGTT beta index.

Conclusions/interpretation

Our findings demonstrate that model-derived parameters of insulin secretion have a substantial genetic component and may be used in the search for genetic determinants of beta cell function in humans.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Flint J, Mott R (2001) Finding the molecular basis of quantitative traits: successes and pitfalls. Nat Rev Genet 2:437–445 Flint J, Mott R (2001) Finding the molecular basis of quantitative traits: successes and pitfalls. Nat Rev Genet 2:437–445
2.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 237:E214–E223PubMed
3.
Zurück zum Zitat Radziuk J (2000) Insulin sensitivity and its measurements: structural commonalities among methods. J Clin Endocrinol Metab 85:4426–4433CrossRefPubMed Radziuk J (2000) Insulin sensitivity and its measurements: structural commonalities among methods. J Clin Endocrinol Metab 85:4426–4433CrossRefPubMed
4.
Zurück zum Zitat Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806 Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806
5.
Zurück zum Zitat Mittelman SD, Van Citters GW, Kim SP et al (2000) Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta cell response. Diabetes 49:2116–2125PubMed Mittelman SD, Van Citters GW, Kim SP et al (2000) Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta cell response. Diabetes 49:2116–2125PubMed
6.
Zurück zum Zitat Henquin J-C, Boitard C, Efendic S, Ferrannini E, Steiner DF, Cerasi E (2002) Editorial. Insulin secretion. Movement at all levels. Diabetes 51(Suppl 1):S1–S2 Henquin J-C, Boitard C, Efendic S, Ferrannini E, Steiner DF, Cerasi E (2002) Editorial. Insulin secretion. Movement at all levels. Diabetes 51(Suppl 1):S1–S2
7.
Zurück zum Zitat Henquin J-C, Ishiyama N, Nenquin M, Ravier MA, Jonas J-C (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51(Suppl 1):S60–S67PubMed Henquin J-C, Ishiyama N, Nenquin M, Ravier MA, Jonas J-C (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51(Suppl 1):S60–S67PubMed
8.
Zurück zum Zitat Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed
9.
Zurück zum Zitat Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476–1483CrossRefPubMed Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476–1483CrossRefPubMed
10.
Zurück zum Zitat Van Haeften T, Pimenta W, Mitrakou A et al (2000) Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and post glucose-load glycaemia. Metabolism 49:1318–1325CrossRefPubMed Van Haeften T, Pimenta W, Mitrakou A et al (2000) Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and post glucose-load glycaemia. Metabolism 49:1318–1325CrossRefPubMed
11.
Zurück zum Zitat Bonadonna RC, Stumvoll M, Fritsche A et al (2003) Altered homeostatic adaptation of first- and second-phase beta cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52:470–480PubMed Bonadonna RC, Stumvoll M, Fritsche A et al (2003) Altered homeostatic adaptation of first- and second-phase beta cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52:470–480PubMed
12.
Zurück zum Zitat Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
13.
Zurück zum Zitat Toffolo G, De Grandi F, Cobelli C (1995) Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of kinetics avoids errors in modelling the secretion. Diabetes 44:845–854PubMed Toffolo G, De Grandi F, Cobelli C (1995) Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of kinetics avoids errors in modelling the secretion. Diabetes 44:845–854PubMed
14.
Zurück zum Zitat Monauni T, Zenti MG, Cretti A et al (2000) Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49:926–935PubMed Monauni T, Zenti MG, Cretti A et al (2000) Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49:926–935PubMed
15.
Zurück zum Zitat Cretti A, Lehtovirta M, Bonora E et al (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416CrossRefPubMed Cretti A, Lehtovirta M, Bonora E et al (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416CrossRefPubMed
16.
Zurück zum Zitat Del Prato S, Marchetti P, Bonadonna RC (2002) Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes (Suppl 1):S109–S116 Del Prato S, Marchetti P, Bonadonna RC (2002) Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes (Suppl 1):S109–S116
17.
Zurück zum Zitat Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and secretion in monozygotic and dizygotic twins. Diabetologia 43:285–293PubMed Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and secretion in monozygotic and dizygotic twins. Diabetologia 43:285–293PubMed
18.
Zurück zum Zitat Kaprio J, Sarna S, Koskenvuo M, Rantasalo I (1978) The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedure, and research program. Prog Clin Biol Res 24:179–184PubMed Kaprio J, Sarna S, Koskenvuo M, Rantasalo I (1978) The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedure, and research program. Prog Clin Biol Res 24:179–184PubMed
19.
Zurück zum Zitat Sarna S, Kaprio J, Sistonen P, Koskenvuo M (1978) Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 28:241–254PubMed Sarna S, Kaprio J, Sistonen P, Koskenvuo M (1978) Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 28:241–254PubMed
20.
Zurück zum Zitat Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337–343PubMed Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337–343PubMed
21.
Zurück zum Zitat Barrett PH, Bell BM, Cobelli C et al (1998) SAAM II: simulation, analysis, and modelling software for tracer and pharmacokinetic studies. Metabolism 47:484–492CrossRefPubMed Barrett PH, Bell BM, Cobelli C et al (1998) SAAM II: simulation, analysis, and modelling software for tracer and pharmacokinetic studies. Metabolism 47:484–492CrossRefPubMed
22.
Zurück zum Zitat Polonsky KS, Licinio-Paixao J, Given BD et al (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98–105PubMed Polonsky KS, Licinio-Paixao J, Given BD et al (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98–105PubMed
23.
Zurück zum Zitat Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed
24.
Zurück zum Zitat Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. NATO ASI Series. Kluwer Academic Publishers, Dordrecht Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. NATO ASI Series. Kluwer Academic Publishers, Dordrecht
25.
Zurück zum Zitat Posthuma D, Beem AL, de Geus EJC et al (2003) Theory and practice in quantitative genetics. Twin Res 6:361–376CrossRefPubMed Posthuma D, Beem AL, de Geus EJC et al (2003) Theory and practice in quantitative genetics. Twin Res 6:361–376CrossRefPubMed
26.
Zurück zum Zitat Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716–723CrossRef Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716–723CrossRef
27.
Zurück zum Zitat Neale MC, Boker SM, Xie G, Maes HH (2002) Mx: statistical modelling, 6th edn. VCU, Department of Psychiatry, Richmond, VA, USA Neale MC, Boker SM, Xie G, Maes HH (2002) Mx: statistical modelling, 6th edn. VCU, Department of Psychiatry, Richmond, VA, USA
28.
Zurück zum Zitat Williams CJ, Christian JC, Norton JA Jr (1992) TWINAN90: a Fortran program for conducting ANOVA-based and likelihood-based analyses of twin data. Comput Methods Programs Biomed 38:167–176CrossRefPubMed Williams CJ, Christian JC, Norton JA Jr (1992) TWINAN90: a Fortran program for conducting ANOVA-based and likelihood-based analyses of twin data. Comput Methods Programs Biomed 38:167–176CrossRefPubMed
29.
Zurück zum Zitat Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1993) Additive insulinotropic effects of exogenous synthetic human gastric-inhibitory polypeptide and glucagon-like peptide-1(7–36) amide infused at near-physiological insulinotropic hormone- and glucose concentrations. J Clin Endocrinol Metab 76:912–917CrossRefPubMed Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1993) Additive insulinotropic effects of exogenous synthetic human gastric-inhibitory polypeptide and glucagon-like peptide-1(7–36) amide infused at near-physiological insulinotropic hormone- and glucose concentrations. J Clin Endocrinol Metab 76:912–917CrossRefPubMed
30.
Zurück zum Zitat Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158PubMed Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158PubMed
31.
Zurück zum Zitat Mari A, Schmitz O, Gastaldelli A, Oestergard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of beta-cell function: modelling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed Mari A, Schmitz O, Gastaldelli A, Oestergard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of beta-cell function: modelling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed
32.
Zurück zum Zitat Lindsten J, Cerasi E, Luft R, Morton N, Ryman N (1976) Significance of genetic factors for the plasma insulin response to glucose in healthy subjects. Clin Genet 10:125–134PubMed Lindsten J, Cerasi E, Luft R, Morton N, Ryman N (1976) Significance of genetic factors for the plasma insulin response to glucose in healthy subjects. Clin Genet 10:125–134PubMed
33.
Zurück zum Zitat Colilla S, Cox NJ, Ehrmann DA (2001) Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027–2031CrossRefPubMed Colilla S, Cox NJ, Ehrmann DA (2001) Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027–2031CrossRefPubMed
34.
Zurück zum Zitat Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283PubMed Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283PubMed
35.
Zurück zum Zitat Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610–630PubMed Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610–630PubMed
36.
Zurück zum Zitat Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788–791CrossRefPubMed Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788–791CrossRefPubMed
37.
Zurück zum Zitat The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
38.
Zurück zum Zitat WHO Consultation Group (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2, Geneva WHO Consultation Group (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2, Geneva
Metadaten
Titel
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins
verfasst von
M. Lehtovirta
J. Kaprio
L. Groop
M. Trombetta
R. C. Bonadonna
Publikationsdatum
01.08.2005
Erschienen in
Diabetologia / Ausgabe 8/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1815-2

Weitere Artikel der Ausgabe 8/2005

Diabetologia 8/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.